Kling Douglas F Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$10.19M

Insider Activity of Kling Douglas F

Biography of Kling Douglas F

No biography is available at this moment.

2025-07-16SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
51,043
0.0459%
$21.10$1.08M+56.93%
2025-07-15SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
47,569
0.0432%
$21.44$1.02M+56.18%
2025-06-16SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
100,000
0.087%
$19.29$1.93M+62.08%
2025-05-15SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
100,000
0.0875%
$18.38$1.84M+67.22%
2025-04-15SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
100,000
0.0902%
$15.71$1.57M+87.02%
2025-03-26SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
16,539
–
$0$0+19.9%
2025-03-17SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
100,000
0.0904%
$23.16$2.32M+13.97%
2025-02-19SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
9,218
0.0083%
$19.23$177,262+27.98%
2025-02-18SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
90,782
0.0834%
$19.54$1.77M+22.01%
2025-01-30SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
13,578
0.0128%
$20.99$284,955+9.32%
2025-01-29SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
56,863
0.0511%
$20.60$1.17M+13.91%
2025-01-28SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
25,385
0.0234%
$21.12$536,254+10.12%
2025-01-27SaleNewAmsterdam Pharma Company N.V.
NAMS
Chief Operating Officer
104,174
0.0973%
$22.69$2.36M+4.42%
Total: 13
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.